Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Jens Lagerstedt

Associate professor

Default user image.

APOLIPOPROTEIN A-I DERIVED PEPTIDES FOR TREATMENT OF HYPERGLYCAEMIA

Other contributions

  • Jens Lagerstedt
  • Karin Stenkula

Summary, in English

The present invention relates to peptides derived from
apolipoprotein A-I (apoA-I) and their use for treatment or prevention of
diseases and disorders associated with hyper-glycaemia.

Department/s

  • Medical Protein Science
  • Glucose Transport and Protein Trafficking
  • EXODIAB: Excellence in Diabetes Research in Sweden

Publishing year

2014-01-27

Language

English

Document type

Patent

Topic

  • Physiology

Keywords

  • apolipoprotein A-i
  • Hyperglycaemia

Status

Published

Research group

  • Medical Protein Science
  • Glucose Transport and Protein Trafficking

ISBN/ISSN/Other

  • https://www.lens.org/lens/patent/019-094-625-110-905